Donor bone marrow transplantation: chimerism and tolerance (Q35893653)

11 August 2017

1 reference

title

Donor bone marrow transplantation: chimerism and tolerance (English)

1 reference

11 August 2017

Spiros Delis

1

1 reference

11 August 2017

Gaetano Ciancio

2

1 reference

11 August 2017

George W Burke

3

1 reference

11 August 2017

Rolando Garcia-Morales

4

1 reference

11 August 2017

Joshua Miller

5

1 reference

11 August 2017

1 September 2004

1 reference

11 August 2017

Transplant Immunology

1 reference

11 August 2017

13

1 reference

11 August 2017

105-115

1 reference

11 August 2017

2

1 reference

Long-term results of a controlled prospective study with transfusion of donor-specific bone marrow in 57 cadaveric renal allograft recipients

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Chimerism and donor-specific nonreactivity 27 to 29 years after kidney allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The lost chord: microchimerism and allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Combined histocompatibility leukocyte antigen-matched donor bone marrow and renal transplantation for multiple myeloma with end stage renal disease: the induction of allograft tolerance through mixed lymphohematopoietic chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Renal transplantation for end-stage renal disease following bone marrow transplantation: a report of six cases, with and without immunosuppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Immunologic tolerance to renal allografts after bone marrow transplants from the same donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Mini-allografts: ongoing trials in humans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance in renal transplantation after allogeneic bone marrow transplantation-6-year follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Mixed chimerism and transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

A nonlethal conditioning approach to achieve engraftment of xenogeneic rat bone marrow in mice and to induce donor-specific tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Cell migration, chimerism, and graft acceptance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Chimerism and transplantation tolerance: cause and effect

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Antiviral T cell competence and restriction specificity of mixed allogeneic (P1 + P2----P1) irradiation chimeras

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Induction of high levels of allogeneic hematopoietic reconstitution and donor-specific tolerance without myelosuppressive conditioning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Bone marrow augmentation of donor-cell chimerism in kidney, liver, heart, and pancreas islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Combined simultaneous kidney/bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Continuing observations on the regulatory effects of donor-specific bone marrow cell infusions and chimerism in kidney transplant recipients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The human bone marrow as an immunoregulatory organ

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Six-year clinical effect of donor bone marrow infusions in renal transplant patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

An assessment of the effects of cadaver donor bone marrow on kidney allograft recipient blood cell chimerism by a novel technique combining PCR and flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Donor bone marrow-derived chimeric cells present in renal transplant recipients infused with donor marrow. I. Potent regulators of recipient antidonor immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Immunoregulatory role of chimerism in clinical organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

High-dose donor bone marrow infusions to enhance allograft survival: the effect of timing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Donor-type microchimerism associated with graft rejection eight years after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Microchimerism and rejection in clinical transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Prospective study of microchimerism in transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Peripheral blood microchimerism in human liver and renal transplant recipients: rejection despite donor-specific chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Karyotypic chimerism and rejection in a pancreaticoduodenosplenic transplant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Three years of follow-up of bone marrow-augmented organ transplant recipients: the impact on donor-specific immune modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Simultaneous administration of adjuvant donor bone marrow in pancreas transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Donor bone marrow infusion in simultaneous pancreas/kidney transplantation with OKT3 induction: evidence for augmentation of chimerism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Higher percentage of donor CD 34+ expression in peripheral blood of simultaneous pancreas/kidney/donor bone marrow versus than kidney/islet cell/donor bone marrow recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance, mixed chimerism and protection against graft-versus-host disease after total lymphoid irradiation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: studies of chimerism and anti-donor reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Human allograft acceptance is associated with immune regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Trans vivo analysis of human delayed-type hypersensitivity reactivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Association of interleukin-10 with rejection-sparing effect in septic kidney transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Advances in transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Routes to allograft survival

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Regulatory functions of self-restricted MHC class II allopeptide-specific Th2 clones in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

inferred from DOI database lookup

7 January 2021

based on heuristic

CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Analysis of the CD40 and CD28 pathways on alloimmune responses by CD4+ T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Induction therapy with monoclonal antibodies specific for CD80 and CD86 delays the onset of acute renal allograft rejection in non-human primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Th1 and Th2 subsets: paradigms lost?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Targeting signal 1 through CD45RB synergizes with CD40 ligand blockade and promotes long term engraftment and tolerance in stringent transplant models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

CD4(+)CD25(+) immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Oral exposure to alloantigen generates intragraft CD8+ regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Efficient presentation of exogenous antigen by liver endothelial cells to CD8+ T cells results in antigen-specific T-cell tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Generation of interferon alpha-producing predendritic cell (Pre-DC)2 from human CD34(+) hematopoietic stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Id2 and Id3 inhibit development of CD34(+) stem cells into predendritic cell (pre-DC)2 but not into pre-DC1. Evidence for a lymphoid origin of pre-DC2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

IL-15 and IL-2: a matter of life and death for T cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Critical role for IL-4 in the development of transplant arteriosclerosis in the absence of CD40-CD154 costimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Donor-derived IP-10 initiates development of acute allograft rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Beneficial effects of targeting CCR5 in allograft recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

CTLA-4 up-regulation plays a role in tolerance mediated by CD45.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Rapamune® (RAPA, rapamycin, sirolimus): mechanism of action immunosuppressive effect results from blockade of signal transduction and inhibition of cell cycle progression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Rapamycin: clinical results and future opportunities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The role of cytokines and adhesion molecules for mobilization of peripheral blood stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Regulation of T cell immunity by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Differential effects of myeloid dendritic cells retrovirally transduced to express mammalian or viral interleukin-10 on cytotoxic T lymphocyte and natural killer cell functions and resistance to tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Bone marrow stromal stem cells: nature, biology, and potential applications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Exploiting dendritic cells to improve vaccine efficacy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance induction in clinical transplantation: the pending questions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance induction by megadose hematopoietic progenitor cells: expansion of veto cells by short-term culture of purified human CD34(+) cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Larger numbers of CD4(bright) dendritic cells in donor bone marrow are associated with increased relapse after allogeneic bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The effect of T cell depletion with Campath-1M on immune reconstitution after chemotherapy and allogeneic bone marrow transplant as treatment for leukaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance protocols and cell transplantation: prospects for the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Prope tolerance: a step in the search for tolerance in the clinic

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance: is it achievable in pediatric solid organ transplantation?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Treatment of streptozotocin-induced diabetes mellitus by transplantation of islet cells plus bone marrow cells via portal vein in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Localized bone marrow transplantation leads to skin allograft acceptance in nonmyeloablated recipients: comparison of intra-bone marrow and isolated limb perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance to solid organ transplants through transfer of MHC class II genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The tolerant recipient: looking great in someone else's genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

How do monoclonal antibodies induce tolerance? A role for infectious tolerance?

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

inferred from DOI database lookup

7 January 2021

based on heuristic

Peripheral microchimerism in long-term cadaveric-kidney allograft recipients

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The evolving concept of a stem cell: entity or function?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Multilineage differentiation from human embryonic stem cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

High-dose peripheral blood stem cell infusion: a strategy to induce donor-specific hyporesponsiveness to allografts in pediatric renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Will xenotransplantation ever be feasible?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Indirect allorecognition in acquired thymic tolerance: induction of donor-specific permanent acceptance of rat islets by adoptive transfer of allopeptide-pulsed host myeloid and thymic dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Tolerance induction by "megadose" hematopoietic transplants: donor-type human CD34 stem cells induce potent specific reduction of host anti-donor cytotoxic T lymphocyte precursors in mixed lymphocyte culture.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

Hematopoietic stem cells need two signals to prevent apoptosis; BCL-2 can provide one of these, Kitl/c-Kit signaling the other

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

The birth of clinical organ transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2004.05.006

10.1016/J.TRIM.2004.05.006

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference